LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Clinical trial NCT06198413 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06198413
- Sponsor
- Innostellar Biotherapeutics Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2024-12-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.